Trial Outcomes & Findings for The Drinking Dashboard Study (NCT NCT05630625)

NCT ID: NCT05630625

Last Updated: 2026-08-07

Results Overview

% of eligible screening participants who (yes/no) complete the baseline assessment (no specific tool)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

169 participants

Primary outcome timeframe

Baseline

Results posted on

2026-08-07

Participant Flow

Participant milestones

Participant milestones
Measure
Drinking Dashboard
Day-level feedback on alcohol use and consequences Drinking Dashboard: Day-level feedback on alcohol use and consequences
Assessment Only
Daily assessment control group
Overall Study
STARTED
87
82
Overall Study
COMPLETED
74
82
Overall Study
NOT COMPLETED
13
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Data for participants included in primary analyses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Drinking Dashboard
n=74 Participants
Day-level feedback on alcohol use and consequences
Assessment Only
n=82 Participants
Daily assessment control group
Total
n=156 Participants
Total of all reporting groups
Age, Continuous
22.11 years
STANDARD_DEVIATION 2.79 • n=20 Participants • Data for participants included in primary analyses
22.07 years
STANDARD_DEVIATION 2.68 • n=20 Participants • Data for participants included in primary analyses
22.09 years
STANDARD_DEVIATION 2.72 • n=40 Participants • Data for participants included in primary analyses
Sex: Female, Male
Female
42 Participants
n=20 Participants
49 Participants
n=20 Participants
91 Participants
n=40 Participants
Sex: Female, Male
Male
32 Participants
n=20 Participants
33 Participants
n=20 Participants
65 Participants
n=40 Participants
Race/Ethnicity, Customized
Asian only
3 Participants
n=20 Participants
6 Participants
n=20 Participants
9 Participants
n=40 Participants
Race/Ethnicity, Customized
Black only
2 Participants
n=20 Participants
3 Participants
n=20 Participants
5 Participants
n=40 Participants
Race/Ethnicity, Customized
Hispanic or Latine only
9 Participants
n=20 Participants
9 Participants
n=20 Participants
18 Participants
n=40 Participants
Race/Ethnicity, Customized
White only
48 Participants
n=20 Participants
49 Participants
n=20 Participants
97 Participants
n=40 Participants
Race/Ethnicity, Customized
Other race
1 Participants
n=20 Participants
0 Participants
n=20 Participants
1 Participants
n=40 Participants
Race/Ethnicity, Customized
Multiracial or Multiethnic
11 Participants
n=20 Participants
15 Participants
n=20 Participants
26 Participants
n=40 Participants
En bloc blackout
55 Participants
n=20 Participants
56 Participants
n=20 Participants
111 Participants
n=40 Participants

PRIMARY outcome

Timeframe: Baseline

% of eligible screening participants who (yes/no) complete the baseline assessment (no specific tool)

Outcome measures

Outcome measures
Measure
Total Screened
n=487 Participants
Total participants that complete initial screening.
Assessment Only
Daily assessment control group
Recruitment
248 Participants

PRIMARY outcome

Timeframe: 3-month follow-up

% of randomized participants who (yes/no) complete 3-month follow-up assessment (no specific tool)

Outcome measures

Outcome measures
Measure
Total Screened
n=87 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Retention
73 Participants
72 Participants

PRIMARY outcome

Timeframe: 1 month follow-up

Measured using the 8-item Client Satisfaction Questionnaire. Scored from 1 to 4, with higher scores indicating greater satisfaction with treatment.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
Daily assessment control group
Acceptability
2.91 units on a scale
Standard Deviation 0.40

PRIMARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: Numbers differ due to attrition.

Measured using the Daily Drinking Questionnaire, which asks participants to indicate how many standard drinks they consumed on each day of a typical week in the past month.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Frequency of High-intensity Drinking
Baseline
3.36 drinks per day
Standard Deviation 3.52
2.91 drinks per day
Standard Deviation 3.25
Frequency of High-intensity Drinking
Post-treatment
2.68 drinks per day
Standard Deviation 3.29
2.18 drinks per day
Standard Deviation 3.01
Frequency of High-intensity Drinking
3 months
1.47 drinks per day
Standard Deviation 2.02
1.88 drinks per day
Standard Deviation 2.66

PRIMARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: Numbers differ due to attrition.

Measured using the Daily Drinking Questionnaire, which asks participants to indicate the maximum number of drinks consumed on one occasion in the past month. Estimated using Widmark's formula (1932).

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Change in Peak BAC From Baseline
Baseline
.20 percentage of alcohol/100 ml of blood
Standard Deviation .09
.19 percentage of alcohol/100 ml of blood
Standard Deviation .10
Change in Peak BAC From Baseline
Post-treatment
0.18 percentage of alcohol/100 ml of blood
Standard Deviation 0.10
0.17 percentage of alcohol/100 ml of blood
Standard Deviation 0.12
Change in Peak BAC From Baseline
3 Months
0.14 percentage of alcohol/100 ml of blood
Standard Deviation 0.94
0.14 percentage of alcohol/100 ml of blood
Standard Deviation 0.11

PRIMARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: Number is different due to attrition.

Measured using the 8-item Alcohol-Induced Blackout Measure-2 (ABOM-2). Participants indicate how often they have experienced 8 different blackout experiences (e.g., having fuzzy memories of drinking events, being unable to remember hours at a time) in the past month on a scale from 0 (never) to 4 (4 or more times). Item scores are summed to create a total score that ranges from 0 to 32, with higher scores indicating more frequent blackout experiences.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Frequency of Blackouts
Baseline
12.82 units on a scale
Standard Deviation 7.78
12.48 units on a scale
Standard Deviation 7.77
Frequency of Blackouts
Post-treatment
8.99 units on a scale
Standard Deviation 7.51
7.46 units on a scale
Standard Deviation 7.06
Frequency of Blackouts
3 Months
6.65 units on a scale
Standard Deviation 6.56
5.66 units on a scale
Standard Deviation 7.07

PRIMARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: Number is different due to attrition.

Measured using the 24-item Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ). Participants indicate (0=no, 1=yes) if they experienced 24 consequences as a result of drinking in the past month. Items are summed to create a total score, with higher scores indicating a greater number of consequences in the past month.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Alcohol-related Consequences
3 Months
6.03 score on a scale
Standard Deviation 5.06
5.75 score on a scale
Standard Deviation 5.48
Alcohol-related Consequences
Baseline
11.39 score on a scale
Standard Deviation 4.77
11.20 score on a scale
Standard Deviation 4.86
Alcohol-related Consequences
Post-treatment
8.59 score on a scale
Standard Deviation 4.80
7.42 score on a scale
Standard Deviation 4.79

SECONDARY outcome

Timeframe: Difference in likelihood baseline vs 3 months

Population: participants

% of people indicating they (a) were coerced into sexual activity or (b) coerced someone else into sexual activity in the past 3 months

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Sexual Coercion
Baseline
16 Participants
16 Participants
Sexual Coercion
Post-treatment
11 Participants
8 Participants
Sexual Coercion
3-month follow-up
7 Participants
5 Participants

SECONDARY outcome

Timeframe: Difference in likelihood baseline vs 3 months

Population: participants

% of people indicating they visited the emergency department in the past 3 months

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Emergency Department Visits
3-month follow-up
2 Participants
1 Participants
Emergency Department Visits
Baseline
3 Participants
7 Participants
Emergency Department Visits
Post-treatment
0 Participants
2 Participants

SECONDARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: participants

How likely is it that you will lose memory of drinking events as a result of alcohol use in the next 30 days? Scored on 0-100 scale, with higher scores indicating more susceptibility.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=81 Participants
Daily assessment control group
Blackout Susceptibility
Baseline
51.32 score on a scale
Standard Deviation 29.07
49.77 score on a scale
Standard Deviation 51.32
Blackout Susceptibility
Post-treatment
40.85 score on a scale
Standard Deviation 30.39
34.25 score on a scale
Standard Deviation 29.66
Blackout Susceptibility
3-month follow-up
32.86 score on a scale
Standard Deviation 31.69
24.34 score on a scale
Standard Deviation 24.53

SECONDARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: participants

Participants responded to 6 items indicating the extent to which they believed that blackouts would be (1) enjoyable, (2) good, (3) beneficial, (4) wise, (5) pleasant, and (6) safe. Responses were strongly disagree =1, disagree = 2, neutral = 3, agree = 4, strongly agree = 5. Scores from each of the six items were averaged, with higher scores indicating more positive expectancies for blackout.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Blackout Expectancies (Scale Developed by Investigators for This Study)
Baseline
3.45 score on a scale
Standard Deviation 4.14
2.91 score on a scale
Standard Deviation 3.19
Blackout Expectancies (Scale Developed by Investigators for This Study)
Post-treatment
3.42 score on a scale
Standard Deviation 4.01
2.64 score on a scale
Standard Deviation 3.30
Blackout Expectancies (Scale Developed by Investigators for This Study)
3-month follow-up
2.89 score on a scale
Standard Deviation 3.38
3.71 score on a scale
Standard Deviation 4.02

SECONDARY outcome

Timeframe: Change from baseline to post-treatment (five weeks later)

Population: participants

Measured using the Alcohol and Drug Consequences Questionnaire scale. Participants indicated the extent to which they agreed with 16 statements regarding the benefits of decreased alcohol use (e.g., I would feel better physically). Responses range 0 (not important / wouldn't happen) to 4 (extremely important). Responses are summed, with higher scores indicating greater perceived benefits of decreasing alcohol use.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=79 Participants
Daily assessment control group
Costs/Benefits of Drinking
Baseline
13.11 score on a scale
Standard Deviation 1.52
13.42 score on a scale
Standard Deviation 1.51
Costs/Benefits of Drinking
Post-treatment
23.61 score on a scale
Standard Deviation 12.04
24.11 score on a scale
Standard Deviation 13.44

SECONDARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: participants

% confidence that participants could avoid a blackout, if they wanted to do so

Outcome measures

Outcome measures
Measure
Total Screened
n=73 Participants
Total participants that complete initial screening.
Assessment Only
n=81 Participants
Daily assessment control group
Blackout Self-efficacy
Post-treatment
82.73 score on a scale
Standard Deviation 20.58
84.91 score on a scale
Standard Deviation 25.16
Blackout Self-efficacy
3-month follow-up
86.08 score on a scale
Standard Deviation 21.64
84.11 score on a scale
Standard Deviation 26.71
Blackout Self-efficacy
Baseline
77.19 score on a scale
Standard Deviation 25.88
77.28 score on a scale
Standard Deviation 27.73

SECONDARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: participants

Measured using the Insomnia Severity Index. Participants rate the extent to which they have struggled with sleep in the past two weeks (e.g., difficulty falling asleep, difficulty staying asleep, worry/distress about sleep). Responses range from 0 (e.g., none) to 4 (e.g., very severe). Items are summed and range 0-28, with higher scores indicating more severe insomnia.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=82 Participants
Daily assessment control group
Sleep Disturbance
Baseline
8.74 score on a scale
Standard Deviation 4.56
11.04 score on a scale
Standard Deviation 5.90
Sleep Disturbance
Post-treatment
8.59 score on a scale
Standard Deviation 4.77
8.91 score on a scale
Standard Deviation 5.42
Sleep Disturbance
3-month follow-up
7.11 score on a scale
Standard Deviation 4.27
8.93 score on a scale
Standard Deviation 5.86

SECONDARY outcome

Timeframe: Change from baseline to follow-up (1 and 3 months)

Population: participants

Measured using the Positive and Negative Affect Schedule. Scores range 1 (very slightly or not at all) to 5 (extremely), with higher scores indicating more negative mood.

Outcome measures

Outcome measures
Measure
Total Screened
n=74 Participants
Total participants that complete initial screening.
Assessment Only
n=81 Participants
Daily assessment control group
Mood
Baseline
23.70 score on a scale
Standard Deviation 8.26
22.58 score on a scale
Standard Deviation 7.50
Mood
3-month follow-up
22.61 score on a scale
Standard Deviation 8.49
22.18 score on a scale
Standard Deviation 6.84
Mood
Post-treatment
22.73 score on a scale
Standard Deviation 7.98
22.65 score on a scale
Standard Deviation 7.12

Adverse Events

Drinking Dashboard

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Assessment Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Mary Beth Miller

University of Missouri

Phone: 573-882-1813

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place